STRENGTHS AND LIMITATIONS OF THIS STUDY
This study leverages a large-scale, repeated cross-sectional survey with a substantial sample size (n=62 744) conducted in 144–143 tertiary hospitals across all 31 provinces of China, enhancing the generalisability of findings within the context of China’s tertiary healthcare system.
By comparing patient experiences immediately before (2019) and during (2021) the COVID-19 pandemic, the study provides a unique and robust natural experiment to analyse the impact of a major public health crisis on healthcare delivery and patient perceptions.
Data were collected using a validated, structured questionnaire that assessed patient experiences across four key dimensions (medical process, service, environment and overall evaluation), ensuring a comprehensive and standardised measurement.
The sampling frame of this study comprised well-established urban tertiary hospitals, which limit the generalisability of the findings to rural populations and patients receiving care in primary healthcare settings.
Despite adjusting for…
This post was originally published on https://bmjopen.bmj.com